Nanostructured polyvinylpyrrolidone-curcumin conjugates allowed for kidney-targeted treatment of cisplatin induced acute kidney injury

Nanostructured polyvinylpyrrolidone-curcumin conjugates allowed for kidney-targeted treatment of cisplatin induced acute kidney injury

Acute kidney injury (AKI) leads to unacceptably high mortality due to difficulties in timely intervention and less efficient renal delivery of therapeutic drugs. Here, a series of polyvinylpyrrolidone (PVP)-curcumin nanoparticles (PCurNP) are designed to meet the renal excretion threshold (∼45 kDa),...

Full description

Bibliographic Details
Main Authors:	Hao Wei, Dawei Jiang, Bo Yu, Dalong Ni, Mengting Li, Yin Long, Paul A. Ellison, Cerise M. Siamof, Liang Cheng, Todd E. Barnhart, Hyung-Jun Im, Faquan Yu, Xiaoli Lan, Xiaohua Zhu, Qianjun He, Weibo Cai
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-01-01
Series:	Bioactive Materials
Subjects:	Nanomedicine Acute kidney injury Kidney targeting Positron emission tomography (PET) imaging Zirconium-89 (89Zr) Nuclear medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452199X2200175X

Similar Items

Production and Semi-Automated Processing of <sup>89</sup>Zr Using a Commercially Available TRASIS MiniAiO Module
by: Vijay Gaja, et al.
Published: (2020-06-01)

Recent Advances in Zirconium-89 Chelator Development
by: Nikunj B. Bhatt, et al.
Published: (2018-03-01)

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with 89Zirconium oxine for PET imaging
by: Pamela Leland, et al.
Published: (2023-06-01)

[<sup>89</sup>Zr]-Atezolizumab-PET Imaging Reveals Longitudinal Alterations in PDL1 during Therapy in TNBC Preclinical Models
by: Adriana V. F. Massicano, et al.
Published: (2023-05-01)

Synthesis and Feasibility Evaluation of a new Trastuzumab Conjugate Integrated with Paclitaxel and 89Zr for Theranostic Application Against HER2‐Expressing Breast Cancers
by: Dr. Joo Hee Jang, et al.
Published: (2019-04-01)

89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors
by: Albert J. Chang, et al.
Published: (2012-01-01)

The Race for Hydroxamate-Based Zirconium-89 Chelators
by: Irene V. J. Feiner, et al.
Published: (2021-09-01)

A Semi Rigid Novel Hydroxamate AMPED-Based Ligand for <sup>89</sup>Zr PET Imaging
by: Lisa Russelli, et al.
Published: (2021-09-01)

89Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations
by: Maryke Kahts, et al.
Published: (2023-11-01)

Cysteine-specific 89Zr-labeled anti-CD25 IgG allows immuno-PET imaging of interleukin-2 receptor-α on T cell lymphomas
by: Jin Hee Lee, et al.
Published: (2022-12-01)

[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis
by: Florian Rosar, et al.
Published: (2024-02-01)

Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PET
by: Ida Friberger, et al.
Published: (2023-08-01)

From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [<sup>89</sup>Zr]Zr-PSMA-DFO
by: Klaus Schomäcker, et al.
Published: (2023-12-01)

Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET
by: Jessica E. Wijngaarden, et al.
Published: (2024-02-01)

Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography
by: Darpan N. Pandya, et al.
Published: (2020-08-01)

In Vitro and In Vivo Characterization of <sup>89</sup>Zirconium-Labeled Lintuzumab Molecule
by: Kevin J. H. Allen, et al.
Published: (2022-10-01)

Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals
by: Xu Zhou, et al.
Published: (2021-11-01)

Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI
by: Laura M. Lechermann, et al.
Published: (2020-07-01)

Preparation of Zirconium-89 Solutions for Radiopharmaceutical Purposes: Interrelation Between Formulation, Radiochemical Purity, Stability and Biodistribution
by: Anton Larenkov, et al.
Published: (2019-04-01)

Comparative Study with 89Y-foil and 89Y-pressed Targets for the Production of 89Zr †
by: Aiman H. Alnahwi, et al.
Published: (2018-09-01)

State borders in ETRS89 coordinates – reality or fiction ?
by: Jiří Poláček
Published: (2015-12-01)

Entropy-based approach to missing-links prediction
by: Federica Parisi, et al.
Published: (2018-07-01)

Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
by: Xiaoyu Fan, et al.
Published: (2023-11-01)

Development and evaluation of 89Zr-trastuzumab for clinical applications
by: Fatemeh Mohammadpour-Ghazi, et al.
Published: (2023-06-01)

Feasibility of PET/CT system performance harmonisation for quantitative multicentre 89Zr studies
by: Andres Kaalep, et al.
Published: (2018-11-01)

HER3 PET Imaging: <sup>68</sup>Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to <sup>89</sup>Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
by: Sara S. Rinne, et al.
Published: (2021-09-01)

In vivo amyloid-β imaging in the APPPS1-21 transgenic mouse model with a 89Zr- labeled monoclonal antibody.
by: Ann-Marie eWaldron, et al.
Published: (2016-03-01)

Expanded Study on the accumulation effect of tourism under the constraint of structure
by: Wang Qiang, et al.
Published: (2017-05-01)

Exact controllability of multiplex networks
by: Zhengzhong Yuan, et al.
Published: (2014-01-01)

Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study
by: Jessica E. Wijngaarden, et al.
Published: (2022-09-01)

Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody
by: Yan Wang, et al.
Published: (2020-01-01)

The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans
by: Kevin S. Thorneloe, et al.
Published: (2019-05-01)

Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm
by: Julian Kirchner, et al.
Published: (2021-01-01)

Synthesis of Zr-89-Labeled Folic Acid-Conjugated Silica (SiO<sub>2</sub>) Microwire as a Tumor Diagnostics Carrier for Positron Emission Tomography
by: Gun Gyun Kim, et al.
Published: (2021-06-01)

Siberia in the Political-Legal Space of Post-Communist Russia (Based on the Materials of the Siberian Human Rights Association «Vienna-89», the Democratic Union, the Newspaper «Free Democratic Siberia»)
by: S. V. Novikov
Published: (2018-03-01)

Density regulation in strictly metric-free swarms
by: D J G Pearce, et al.
Published: (2014-01-01)

Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of <sup>89</sup>Zr Immune-PET Tracers
by: Ryota Imura, et al.
Published: (2021-08-01)

<sup>89</sup>Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs
by: Iris H. C. Miedema, et al.
Published: (2023-11-01)

Preclinical PET and MR Evaluation of <sup>89</sup>Zr- and <sup>68</sup>Ga-Labeled Nanodiamonds in Mice over Different Time Scales
by: Gordon Winter, et al.
Published: (2022-12-01)

Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma
by: Puey-Ling Chia, et al.
Published: (2020-10-01)